M E N U

Cancer immunotherapy with oncolytic viruses

The mission of our company is

to increase the duration and quality of life by promoting
new technologies aimed at the treatment of oncological diseases.

NIVIRON

Is a preclinical stage company translating technologies for cancer treatment to bedside

Founding Niviron INC

Company mission

Our focus

The main task

The motive of company creation

July 30, 2021
registered State of Delaware, USA

Increasing human longevity through the development of new technologies for the treatment of diseases

Cancer therapy with oncolytic viruses

Build an infrastructure that allows bringing technologies for the treatment of diseases to the market

There are many unresolved problems and tasks in medicine, as well as there is a clear confidence we want to and can solve them

The appeal of the founders

Hello, we are starting an amazing and at the same time difficult path - the search for a technology that can solve at least some of the problems in modern oncology.
We will not say our company is the best. We will not say our company will be the leader in this industry, that we have the best technology. But we assure you that we will spend the rest of our life (I hope the success of our company will prolong it) in order to solve as many problems as possible that are facing today's science.
These problems can be solved only collectively, using hundreds of years of scientific experience of many people. This is exactly what we will do - promoting scientific discoveries to the market.

Our technology

Abstract
Our technology is based on an invention that uses a modified variant of the CVB3 wild type, isolated after serial passaging in human fetal primary fibroblast cells. The new CVB3 – variant (PD-0) shows strong lytic effectiveness in tumor cells and inhibits the tumor growing in vivo without causing side effects.
Possible indications:
  • colorectal carcinoma,
  • esophageal cancer,
  • breast cancer,
  • lung cancer,
  • pancreatic cancer,
  • prostate cancer,
  • stomach cancer and liver cancer
  • Inventors:
  • Henry Fechner
  • Ahmet Hazini
  • Vanessa Brueckner
  • Technology patent
    Granted patent US 10,639,337 B Coxsackievirus B3 Variant PD a novel oncolytic virus International patent application PCT/EP2018/076624 and the application derived thereof: AU 2018342994, CA 3,076,277, CN 201880072804.9, EP18788679.1

    Founders

    Vitaly is a graduate of Kuban State University with a degree in “Journalism”. He has a Master Degree of PR. Currently, he is graduating from the Open British University. In different years, he completed internships in the specialty in the USA, Great Britain and Germany.

    Vitaly was awarded the honorary badge of the President Program of the Russian Federation for the training of managerial personnel for the real sector of the economy. In 2002, Vitaly founded the agency https://gcav.ru/. And he is the general director at the present time.

    Areas of responsibility:

    1. Search for technologies for licensing
    2. Technology commercialization
    3. Search for financing
    4. Team formation
    5. Strategy
    6. Implementation of the development plan
    7. Finance, legal issues
    8. Intellectual property
    9. Creation and development of technologies, science

    About

    38 years

    10 years of entrepreneurship, investor’s capital management experience ($1.5 million budget)

    3 attracted investors in business projects

    «Since early childhood, I have been interested in science, especially medicine and astronomy. Already at school I realized that I wanted to become a doctor. I had all the prerequisites: I was several years ahead of the biology curriculum, participated in two city biology olympiads and won twice. I also participated in the regional olympiad (the region is like a state in the USA), I took 6th place. It was my last year at school, so I had no opportunity to improve the result…..

    But eventually I entered to another university. At that time, I could not afford to pay for my tuition, and I thought I would not be able to enter the university on a budgetary basis…. During that period, I had a lot of other people’s opinions in my head and there was no understanding that if you want something, you just need to do (sometimes a lot), even if it seems impossible. In general, it was a manifestation of weakness and betrayal of my dream.

    I paid in full for my weakness – for more than 10 years I lived other people’s dreams and goals, doing things that do not bring pleasure. But on the other hand, now I understand — it was for the best. Because I got a lot of necessary skills that I would not have received working as a doctor. Perhaps I would not have set the goal that I have now, because I would have worked in a narrowly specialized field (although I am sure I would have been a very good specialist). It’s just sad it took me so long to remember what I want to do and put other people’s opinions, goals and expectations out of my head. The goal I have already mentioned several times is the cardinal prolongation of human life. This task requires breakthroughs in many areas, for example, in the treatment of cancer, CNS diseases and so on. There are a lot of unsolved problems in these areas and I decided to spend the rest of my life solving them.» — Nikita shares.

    Resume submission form